These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28835494)

  • 21. KSHV lytic proteins K-RTA and K8 bind to cellular and viral chromatin to modulate gene expression.
    Kaul R; Purushothaman P; Uppal T; Verma SC
    PLoS One; 2019; 14(4):e0215394. PubMed ID: 30998737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
    Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
    Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.
    Toth Z; Brulois K; Lee HR; Izumiya Y; Tepper C; Kung HJ; Jung JU
    PLoS Pathog; 2013; 9(12):e1003813. PubMed ID: 24367262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
    Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
    PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
    Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
    Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4.
    Asha K; Balfe N; Sharma-Walia N
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32102879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation.
    Liao W; Tang Y; Lin SF; Kung HJ; Giam CZ
    J Virol; 2003 Mar; 77(6):3809-15. PubMed ID: 12610155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel role of SIRT1 in gammaherpesvirus latency and replication.
    He M; Gao SJ
    Cell Cycle; 2014; 13(21):3328-30. PubMed ID: 25485577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
    Yang Z; Yan Z; Wood C
    J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KSHV Rta Promoter Specification and Viral Reactivation.
    Guito J; Lukac DM
    Front Microbiol; 2012; 3():30. PubMed ID: 22347875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major Histocompatibility Complex Class II HLA-DRĪ± Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.
    Sun Z; Jha HC; Pei YG; Robertson ES
    J Virol; 2016 Sep; 90(18):8047-58. PubMed ID: 27356905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.
    Li S; Hu H; He Z; Liang D; Sun R; Lan K
    PLoS Pathog; 2016 Oct; 12(10):e1005900. PubMed ID: 27760204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cellular Notch1 protein promotes KSHV reactivation in an Rta-dependent manner.
    DeCotiis-Mauro J; Han SM; Mello H; Goyeneche C; Marchesini-Tovar G; Jin L; Bellofatto V; Lukac DM
    J Virol; 2024 Aug; 98(8):e0078824. PubMed ID: 38975769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
    Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
    J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88.
    Zhao Q; Liang D; Sun R; Jia B; Xia T; Xiao H; Lan K
    J Virol; 2015 Jan; 89(1):415-27. PubMed ID: 25320320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.